Scott Goldsmith

1.4k total citations
62 papers, 498 citations indexed

About

Scott Goldsmith is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Scott Goldsmith has authored 62 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 20 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Scott Goldsmith's work include Multiple Myeloma Research and Treatments (16 papers), Hematopoietic Stem Cell Transplantation (9 papers) and CAR-T cell therapy research (9 papers). Scott Goldsmith is often cited by papers focused on Multiple Myeloma Research and Treatments (16 papers), Hematopoietic Stem Cell Transplantation (9 papers) and CAR-T cell therapy research (9 papers). Scott Goldsmith collaborates with scholars based in United States, Switzerland and France. Scott Goldsmith's co-authors include John F. DiPersio, Paul Chinowsky, M WILSON, Paul B. Larsen, Ken Strzepek, Mark A. Schroeder, Michael Slade, Rizwan Romee, Peter Westervelt and Armin Ghobadi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Scott Goldsmith

50 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Goldsmith United States 12 162 115 89 83 78 62 498
Simon Griffiths United Kingdom 13 53 0.3× 118 1.0× 121 1.4× 14 0.2× 40 0.5× 38 625
E A Gilman United Kingdom 13 90 0.6× 176 1.5× 54 0.6× 10 0.1× 44 0.6× 18 631
Henry Penn United Kingdom 15 66 0.4× 66 0.6× 231 2.6× 8 0.1× 64 0.8× 40 1.1k
J.A. Bassein United States 3 90 0.6× 32 0.3× 139 1.6× 56 0.7× 15 0.2× 4 453
Ana Iglesias Spain 10 23 0.1× 36 0.3× 86 1.0× 27 0.3× 36 0.5× 25 692
Florence Suzan France 9 198 1.2× 166 1.4× 109 1.2× 31 0.4× 9 0.1× 38 772
Alex Harvey United States 12 76 0.5× 46 0.4× 82 0.9× 11 0.1× 94 1.2× 35 1.4k
E. Lie Norway 22 615 3.8× 56 0.5× 121 1.4× 64 0.8× 12 0.2× 57 2.5k
Kirsten Jenkins United States 13 176 1.1× 70 0.6× 73 0.8× 5 0.1× 30 0.4× 29 475

Countries citing papers authored by Scott Goldsmith

Since Specialization
Citations

This map shows the geographic impact of Scott Goldsmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Goldsmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Goldsmith more than expected).

Fields of papers citing papers by Scott Goldsmith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Goldsmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Goldsmith. The network helps show where Scott Goldsmith may publish in the future.

Co-authorship network of co-authors of Scott Goldsmith

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Goldsmith. A scholar is included among the top collaborators of Scott Goldsmith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Goldsmith. Scott Goldsmith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Htut, Myo, et al.. (2024). Case report: Treatment of parkinsonism secondary to ciltacabtagene autoleucel using a combination dopaminergic regimen. Frontiers in Immunology. 15. 1444010–1444010. 5 indexed citations
3.
Goldsmith, Scott, Geoffrey Shouse, F. Lennie Wong, et al.. (2024). Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy. Transplantation and Cellular Therapy. 30(9). 927.e1–927.e9. 5 indexed citations
4.
Goldsmith, Scott, Michael Slade, Mark A. Fiala, et al.. (2024). A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma. Annals of Hematology. 103(11). 4557–4565. 1 indexed citations
5.
Rhee, June‐Wha, Sitong Chen, Raju Pillai, et al.. (2024). Clonal Hematopoiesis Is Associated with Non-Myeloid Subsequent Malignant Neoplasms after Autologous Hematopoietic Cell Transplantation. Blood. 144(Supplement 1). 947–947. 1 indexed citations
6.
Goldsmith, Scott, Geoffrey Shouse, F. Lennie Wong, et al.. (2023). Clonal Hematopoiesis Is Associated with Severe Cytokine Release Syndrome in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy. Blood. 142(Supplement 1). 4814–4814.
7.
Goldsmith, Scott, et al.. (2022). Chimeric Antigen Receptor T Cell Therapy versus Hematopoietic Stem Cell Transplantation: An Evolving Perspective. Transplantation and Cellular Therapy. 28(11). 727–736. 5 indexed citations
8.
Goldsmith, Scott, et al.. (2022). Bispecific Antibodies for the Treatment of Multiple Myeloma. Current Hematologic Malignancy Reports. 17(6). 286–297. 6 indexed citations
9.
Goldsmith, Scott, Mark A. Fiala, Brandon Wang, et al.. (2020). DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma. Annals of Hematology. 99(5). 1041–1048. 13 indexed citations
10.
Moreau, Philippe, Cyrille Touzeau, Ravi Vij, Scott Goldsmith, & Ashley Rosko. (2020). Newly Diagnosed Myeloma in 2020. American Society of Clinical Oncology Educational Book. 40(40). e144–e158. 16 indexed citations
11.
King, Justin, Mark A. Fiala, Scott Goldsmith, et al.. (2019). Utilization of Autologous Stem Cell Transplantation in Older Patients with Newly Diagnosed Multiple Myeloma. Blood. 134(Supplement_1). 5701–5701.
12.
Goldsmith, Scott, Mark A. Fiala, Julie O’Neal, et al.. (2019). EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms. Clinical Lymphoma Myeloma & Leukemia. 19(11). 744–750. 10 indexed citations
13.
Goldsmith, Scott, Mark A. Fiala, Armin Ghobadi, et al.. (2019). Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study. Clinical Lymphoma Myeloma & Leukemia. 19(5). 285–289. 15 indexed citations
14.
15.
Goldsmith, Scott, Michael Slade, John F. DiPersio, et al.. (2017). Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy. Bone Marrow Transplantation. 52(12). 1623–1628. 19 indexed citations
16.
Goldsmith, Scott, et al.. (2013). Sarcoidosis Manifesting as a Pseudotumorous Renal Mass. Journal of Radiology Case Reports. 7(5). 23–34. 13 indexed citations
17.
Goldsmith, Scott. (2007). The Remote Rural Economy of Alaska. ScholarWorks - UA (University of Alaska System). 21 indexed citations
18.
Goldsmith, Scott, et al.. (2003). Alaska's Budget: Where the Money Came From and Went, 1990-2002. ScholarWorks - UA (University of Alaska System).
19.
Goldsmith, Scott, et al.. (2001). Racial and Ethnic Diversity in Anchorage. European Journal of Medicinal Chemistry. 44(8). 3217–27. 1 indexed citations
20.
Goldsmith, Scott. (1994). Implications of oil supply uncertainty on a small oil‐producing regional economy. OPEC Review. 18(s3). 391–412. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Griffiths Breakdown of academic impact, for papers by E A Gilman Breakdown of academic impact, for papers by Henry Penn Breakdown of academic impact, for papers by J.A. Bassein Breakdown of academic impact, for papers by Ana Iglesias Breakdown of academic impact, for papers by Florence Suzan Breakdown of academic impact, for papers by Alex Harvey Breakdown of academic impact, for papers by E. Lie Breakdown of academic impact, for papers by Kirsten Jenkins
Rankless by CCL
2026